Innovita Biological Technology Co., Ltd. (SHA:688253)

China flag China · Delayed Price · Currency is CNY
31.78
+1.03 (3.35%)
At close: Oct 31, 2025
3.35%
Market Cap4.31B
Revenue (ttm)430.96M
Net Income (ttm)133.44M
Shares Out134.87M
EPS (ttm)0.97
PE Ratio32.81
Forward PE29.06
Dividend0.56 (1.75%)
Ex-Dividend DateJun 24, 2025
Volume3,479,548
Average Volume1,921,735
Open30.64
Previous Close30.75
Day's Range30.16 - 31.86
52-Week Range27.56 - 45.59
Beta1.01
RSI57.18
Earnings DateOct 31, 2025

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, focuses on the research and development, production and sales of POCT rapid diagnostic products. The company offers pathogen detection and joint detection of multiple pathogen; gastrointestinal virus testing; respiratory tract infections solutions; pregnancy test; hepatitis virus testing; and eugenics testing. The company was founded in 2006 and is based in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 547
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688253
Full Company Profile

Financial Performance

In 2024, SHA:688253's revenue was 621.39 million, an increase of 29.99% compared to the previous year's 478.02 million. Earnings were 246.86 million, an increase of 41.92%.

Financial Statements

News

There is no news available yet.